Table V.
Accuracy of PET/CT assessment on the effect of neoadjuvant therapy on patients with osseous and soft tissue sarcomas in the included studies.
| Authors | TP | FP | FN | TN | Sensitivity (95% CI) | Specificity (95% CI) | (Refs.) |
|---|---|---|---|---|---|---|---|
| Benz et al | 3 | 1 | 1 | 7 | 0.75 (0.19–0.99) | 0.88 (0.47–1.00) | (18) |
| Byun et al | 8 | 2 | 4 | 13 | 0.67 (0.35–0.90) | 0.87 (0.60–0.98) | (20) |
| Byun et al | 11 | 1 | 1 | 8 | 0.92 (0.62–1.00) | 0.89 (0.52–1.00) | (21) |
| Evilevitch et al | 8 | 10 | 0 | 24 | 1.00 (0.63–1.00) | 0.71 (0.53–0.85) | (16) |
| Hamada et al | 5 | 0 | 0 | 4 | 1.00 (0.48–1.00) | 0.88 (0.40–1.00) | (17) |
| Iagaru et al | 3 | 1 | 3 | 7 | 0.50 (0.12–0.88) | 0.88 (0.47–1.00) | (15) |
| Im et al | 6 | 4 | 3 | 7 | 0.67 (0.30–0.93) | 0.64 (0.31–0.89) | (19) |
| Total | 44 | 19 | 12 | 70 | 0.79 (0.30–0.93) | 0.79 (0.69–0.89) |
PET, positron emission tomography; CT, computed tomography; TP, true-positive; TN, true-negative; FP, false-positive; FN, false-negative; CI, confidence interval.